ngr-htnf
Peptideexperimental
Clinical trial activity
17 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
13
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 2005 (NCT00419328)
Timeline
Indications
Studied for
- Carcinoma, Hepatocellular · Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 2
- Colonic Neoplasms · Phase 2
- Colorectal Neoplasms · Phase 2
- Lymphoma, Large B-Cell, Diffuse · Phase 2
- Mesothelioma · Phase 2
- Mesothelioma, Malignant · Phase 3
- Neoplasm Metastasis · Phase 2
- Neoplasms · Phase 1
- Ovarian Neoplasms · Phase 2
- Small Cell Lung Carcinoma · Phase 2
Mechanism of action
- Aminopeptidase NINHIBITOR
ANPEP inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- ngr-htnf
- ngr-htnf
- ngr-tnf, human
- tumor necrosis factor-alpha, cngrc fusion protein, human
- umor necrosis factor-alpha, cngrc fusion protein, human
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03536039 | Phase 2 | Jan 27, 2016 | MolMed S.p.A., The Foundation Institute San Raffaele G. Giglio of Cefalù, University of Roma La Sapienza, Vita-Salute University of Milano. Italy |
| NCT03804866 | Phase 2 | Mar 31, 2013 | MolMed S.p.A. |
| NCT01358071 | Phase 2 | Jun 1, 2011 | MolMed S.p.A. |
| NCT01358084 | Phase 2 | Mar 1, 2011 | MolMed S.p.A. |
| NCT00484341 | Phase 2 | Oct 1, 2010 | MolMed S.p.A. |
| NCT01098266 | Phase 3 | Mar 1, 2010 | MolMed S.p.A. |
| NCT00994097 | Phase 2 | Jul 1, 2009 | MolMed S.p.A. |
| NCT00878111 | Phase 1 | Apr 1, 2009 | MolMed S.p.A. |
| NCT00484432 | Phase 2 | Nov 1, 2008 | MolMed S.p.A. |
| NCT00675012 | Phase 2 | Dec 1, 2007 | MolMed S.p.A., University of Genoa |
| NCT00483093 | Phase 1 | Jul 1, 2007 | MolMed S.p.A. |
| NCT00484276 | Phase 2 | May 1, 2007 | MolMed S.p.A. |
| NCT00483509 | Phase 2 | Dec 1, 2006 | MolMed S.p.A. |
| NCT00484211 | Phase 2 | Dec 1, 2006 | MolMed S.p.A. |
| NCT00483080 | Phase 2 | Dec 1, 2006 | MolMed S.p.A., Vita-Salute University of Milano. Italy |
| NCT00305084 | Phase 1 | Jan 1, 2006 | MolMed S.p.A., Vita-Salute University of Milano. Italy |
| NCT00419328 | Phase 1 | Mar 1, 2005 | MolMed S.p.A. |
Showing 17 of 17 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MolMed S.p.A. | For profit | 17 | 16 | 3 | 2005 |
| Vita-Salute University of Milano. Italy | Academic/Hospital | 3 | 0 | 2 | 2006 |
| The Foundation Institute San Raffaele G. Giglio of Cefalù | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Genoa | Academic/Hospital | 1 | 0 | 1 | 2007 |
| University of Roma La Sapienza | Academic/Hospital | 1 | 1 | 1 | 2016 |
5 organizations
Page 1 / 1